منابع مشابه
GANIL / SPIRAL 2001 - 2007 Achievements , Highlights and Perspectives
VI. Study of asymmetric nuclear matter at low energy-O. E342aS-Spectroscopic studies of β-delayed multi-proton emission-B. Blank et al.………………………………………………..117 E344aS-Shape coexistence near the N=Z line investigated by low-energy Coulomb excitation of secondary reaction products " and " Shape coexistence near the N=Z line and collective properties of Kr isotopes investigated by low-energy Coulom...
متن کاملHighlights of the 2007 scientific sessions of the European Society of Cardiology Vienna, Austria, September 1-5, 2007.
s p e c ( t p he annual congress of the European Society of Cardiology ESC) was held in Vienna, Austria, September 1 to 5, 2007. he total attendance was close to 30,000 participants from 36 different countries. Excellent new congress facilities osted 186 prearranged sessions (28 meeting rooms running n parallel), including several joint sessions organized in ollaboration with other societies, i...
متن کاملARGOS: dynamic composition of web services for goods movement analysis and planning (project highlights 2007)
Poster. We highlight the latest developments in the Argos project. First, we describe our approach to automatic workflow composition. Second, we discuss the validation of the freight estimation workflow. Third, we discuss some extensions of the model to residential land value analysis.
متن کاملMCBS Highlights: Prevalence of Select Psychiatric Diagnoses in Long-Term Care: 1997-2007
The Medicare Current Beneficiary Survey (MCBS) is a longitudinal survey of a nationally representative sample of Medicare enrollees. The survey collects information on a variety of topics including beneficiaries' health status. This information is collected from two groups of beneficiaries: those living in the community and those living in facilities. Information is obtained on specific medical...
متن کاملSan Antonio Breast Cancer Symposium 2007—Adjuvant endocrine therapy update: ATAC 100 highlights
The two main classes of adjuvant hormonal therapy used in the treatment of postmenopausal women with hormone receptor–positive breast cancer are selective estrogen receptor modulators (for example , tamoxifen) and the aromatase inhibitors (AIs—for example, anastrozole, letrozole, exemestane). The " gold standard " of 5 years of ad-juvant tamoxifen has clearly been challenged (and some would arg...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Der Gastroenterologe
سال: 2008
ISSN: 1861-9681,1861-969X
DOI: 10.1007/s11377-007-0142-1